Nancy E. Reid, MHA, DHSc, PA-C, DFAAPA
Background: Depression during perimenopause is common and frequently untreated in women. This article serves to review the current research on perimenopausal and depression treatment for women between the ages of 40 and 60 years.
Method: A clinical review of literature has been conducted.
Conclusion: Early intervention with antidepressants, SSRI’s and/or SNRI’s, with concurrent talk therapy should be considered first line treatment of perimenopausal depression. Primary care providers, women’s health providers, and mental health providers should initiate treatment with an SSRI and refer for therapy at first symptom emergence for best treatment outcome.
Pastelak RD. Reviewing Treatment Efficacies for Perimenopausal Depression. Lynchburg Journal of Medical Science. 2021; 3(4).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.